Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity)
Mohammad Vodjgani
Mohammad Vodjgani

Professor of Medical Immunology

Department Immunology

School of Medicine

Translational Ophthalmology Research Center

Tehran University of Medical Sciences

Related Documents
All Documents